Diagnosis preceded effective treatment
Physicians could recognize diabetes through symptoms and urine long before they could alter its course. That gap between diagnosis and therapy defined much of pre-insulin diabetes history.
Topic
History of Diabetes and Insulin
Diabetes was recognized long before modern endocrinology could explain it. Physicians described thirst, wasting, sweet urine, and fatal decline, but for centuries treatment remained limited to regimen, diet, and uncertain theories of digestion, kidneys, and metabolism.
The discovery of insulin transformed diabetes from a frequently fatal condition into a chronic disease that could be managed, while also making patients dependent on laboratory production, supply chains, measurement, daily discipline, and access to continuing care.
Discovery
Insulin changed the prognosis of diabetes
Before insulin, strict diets could sometimes prolong life but often left patients weak, hungry, and still in danger. The Toronto work of Frederick Banting, Charles Best, J.J.R. Macleod, and James Collip changed what treatment could mean.
The insulin therapy timeline entry marks 1921 as a turning point, when pancreatic extracts lowered blood sugar in experimental animals and were soon refined for human use. Leonard Thompson's treatment in 1922 became one of the emblematic moments of twentieth-century therapeutic medicine.
Insulin also belongs to the history of medical infrastructure. It required animal pancreases, purification, standardization, commercial manufacture, refrigerated supply, clinical supervision, and later home monitoring. The therapy was life-saving, but never simple.
From symptom to hormone
Laboratory physiology connected diabetes to the pancreas
Nineteenth-century chemistry made sugar in urine and blood increasingly measurable. Experimental removal of the pancreas then produced severe diabetes in animals, helping researchers locate metabolic control in an organ rather than in the kidneys alone.
Microscopy had already identified clusters later called the islets of Langerhans. The hypothesis that these cells released an internal secretion encouraged repeated attempts to prepare a pancreatic extract without the digestive enzymes destroying or contaminating it.
Toronto's achievement was therefore both new and cumulative. Banting's experimental idea, Best's laboratory work, Macleod's facilities and physiological direction, Collip's purification, animal labour, clinical judgement, and patient participation all contributed. Disputes over the Nobel Prize reveal how institutions compress collaboration into a few names.
Chronic Care
Diabetes made modern patients managers of daily treatment
Insulin made survival depend on routine
The drug required timing, dose adjustment, diet, testing, and patient education. Diabetes care therefore became a collaboration between medical systems and daily life.
Access remained part of the history
Insulin's promise depended on cost, supply, medical supervision, and reliable distribution. The history of diabetes is therefore also a history of unequal access to life-sustaining therapy.
Production and daily life
A discovery became treatment through standardisation
Early extracts varied in strength and purity. Connaught Laboratories and pharmaceutical manufacturers developed larger-scale production, testing, and dosage standards. Patents and licensing were intended to supervise quality while industrial collaboration supplied far more patients.
Longer-acting preparations, disposable syringes, portable glucose meters, pumps, recombinant human insulin, and continuous monitors repeatedly changed self-care. Each technology offered flexibility while adding new requirements for education, supplies, interpretation, and maintenance.
Insulin did not eliminate diet, exercise, or the risk of complications. It created a lifetime relationship among patients, families, clinicians, manufacturers, pharmacies, laboratories, and health systems. Cost and interrupted supply can turn a treatable condition back into an emergency.
Reading path
Follow insulin from laboratory to access
Continue with the University of Toronto, Frederick Banting, and medical laboratories. The Connaught history of insulin production explains the transition from experimental extract to supervised manufacture.